Investigators have found that combined treatment with two cancer immunotherapy drugs – one a novel immune modulator and one that focuses and activates the anti-tumor immune response – significantly prolonged survival in mouse models of the aggressive cancer malignant mesothelioma.
from Top Health News – ScienceDaily http://bit.ly/2GtqHvj
from Tumblr http://bit.ly/2pXwxus
No comments:
Post a Comment